Written and maintained by CASRAI Editorial Board
Published
On this page
The Aerogen Solo is a single-patient-use vibrating mesh nebulizer that sits in-line in a ventilator circuit and runs on electricity from a controller rather than on compressed gas. The FDA classifies the device type as a Class 2 “Nebulizer (Direct Patient Interface)” under 21 CFR 868.5630. PARI Vios is not a competing nebulizer: it is a compressor, paired here with the LC Sprint reusable jet nebulizer.
This page describes products and general use; it is not medical advice.
Short answer
Aerogen Solo is a prescription, single-patient-use nebulizer cleared by the FDA (510(k) K232507, decision dated 2024-05-10) to aerosolize physician-prescribed medications for patients on and off ventilation or other positive pressure breathing assistance in the hospital. A mesh element vibrates at roughly 128 kHz to make the aerosol. PARI Vios with LC Sprint is a different technology: a compressor pushes air through a reusable jet nebulizer.
Definition and scope
“Aerogen Solo” is the name of a nebulizer, but the FDA clearance covers a system. The 510(k) summary title is “Aerogen Solo Nebulizer System and Aerogen USB Controller System”, submitted by Aerogen Ltd under product code CAF. In practice a user handles two kinds of component: the Solo nebulizer itself, which is the disposable single-patient part, and a controller that supplies power and drives the mesh. The Solo Nebulizer System was cleared with the Aerogen USB Controller System; the earlier instruction manual we cite below pairs the Solo with the Aerogen Pro-X Controller.
The two other names people search with it are different kinds of object, and mixing them up is the most common source of confusion:
- PARI Vios is an air compressor. It is the power source for a jet nebulizer, not a nebulizer.
- LC Sprint is the reusable jet nebulizer that PARI supplies with the Vios in the product bundle “PARI Vios with LC Sprint”.
- PARI LC Plus, the better-known sibling nebulizer, is covered separately in our PARI LC Plus guide, and the general category is explained in what is a nebulizer.
This page stays at the level of what each manufacturer and regulator document states. It does not give operating or setup steps, dosing, or advice about any individual patient; those belong to the manufacturer’s instructions for use (IFU) and the prescriber.
What the FDA record says about Aerogen Solo
The FDA 510(k) decision letter and summary for K232507 (decision date 2024-05-10) is the most authoritative public description of what the device is cleared to do. The device is a prescription device (21 CFR 801 Subpart D). The primary predicate named in the summary is K133360. The classification record for product code CAF lists “Nebulizer (Direct Patient Interface)”, device Class 2, regulation 21 CFR 868.5630.
Indications as written in the clearance
The summary states that the Solo Nebulizer System is intended to aerosolize physician-prescribed medications for inhalation to patients on and off ventilation or other positive pressure breathing assistance in the hospital environment. For the USB Controller System, the same wording applies and it adds use on ventilation only in the homecare environment. The Solo nebulizer is for single-patient use, for pediatric patients 29 days or older and adult patients.
Two documents, two generations
Readers often compare the 2024 clearance with older manuals found online and think they contradict each other. They describe different controller generations, so read them side by side:
| Document | Controller named | Setting stated |
|---|---|---|
| FDA 510(k) K232507 summary (2024) | Aerogen USB Controller System | Hospital environment; homecare on ventilation only for the USB Controller System |
| Aerogen Solo System Instruction Manual, 30-674 Rev L (US) | Aerogen Pro-X Controller | “Hospital use only” |
FDA’s openFDA database also lists a separate later clearance, K251615 for the Aerogen Pro-X1 Controller System (decision 2025-09-02, product code SFP). Whether a particular nebulizer and controller combination is covered by a particular clearance is a question for the manufacturer’s current labelling, which is why a supply team should match the controller model to the IFU revision that ships with it.
How a vibrating mesh nebulizer works, and how a jet nebulizer differs
Aerogen Solo: vibrating mesh, electrically driven
According to the 510(k) summary, the Solo uses a vibrating mesh element operating at approximately 128 kHz. It needs no compressed gas source. It aerosolizes continuously during both inhalation and exhalation, and it fits into a standard ventilator circuit without changing the patient ventilator parameters. The summary also states that the nebulizer can be refilled without breaking the circuit. The reservoir holds a maximum of 6 mL.
The instruction manual (Rev L) gives further engineering detail: the nebulizer measures 67 x 48 x 25 mm and weighs 13.5 g; it operates at up to 90 cm H2O circuit pressure across 5 to 45 °C; noise is below 35 dB at 0.3 m. For performance, it reports a flow rate above 0.2 mL/min (average about 0.38 mL/min), a particle size specification range of 1 to 5 µm, and a tested average of 3.1 µm using an Andersen cascade impactor. Under the EN 13544-1 method it reports an aerosol output rate of 0.30 mL/min with 1.02 mL emitted from a 2.0 mL dose, and a residual volume below 0.1 mL for a 3 mL dose. The manual adds: “Performance may vary depending upon the type of drug and nebulizer used.”
In the 510(k) summary, particle testing was done by cascade impactor at 28.3 L/min and by Next Generation Impactor at 15 L/min, and the biocompatibility and gas pathway standards listed include the ISO 10993 series and ISO 18562-2, -3 and -4. The summary also lists ISO 13544-1, which it notes has been superseded by ISO 27427.
PARI Vios with LC Sprint: compressor plus reusable jet nebulizer
PARI’s product page for Vios with LC Sprint describes a bundle: the Vios compressor, an LC Sprint reusable nebulizer, a backup nebulizer, tubing and instructions. The compressor’s stated maximum pressure is 34 PSI (2.3 bar) and maximum flow 8.5 L/min; when used with a PARI LC reusable nebulizer its nominal values are 18 PSI (1.2 bar) and 4.5 L/min. The compressor weighs 3 lbs and measures 6.5 x 6.5 x 3.75 in, and the page lists a five-year compressor warranty. The page lists adult and pediatric use, part number 310F35-LCS, and the billing codes HCPCS E0570 (compressor) and A7005 (reusable nebulizer).
That product page does not publish particle size, output rate or residual volume for the Vios and LC Sprint combination, so those figures are not compared here. A mesh figure and a jet figure are only comparable when produced by the same test method, and the Aerogen numbers above are given under EN 13544-1 and cascade impactor conditions that PARI’s page does not restate.
The data table
The data table below compares the attributes that both manufacturers’ documents actually state, and marks the rest as not stated. It can be downloaded as CSV or JSON.
Single-patient use and service life
This is where the two systems differ most for anyone who plans supplies or training. Per the Aerogen Solo instruction manual (Rev L), the nebulizer is for single-patient use and must not be used on more than one patient, to prevent cross infection. The components “as packaged, are not sterile”. The manual also says not to attempt to clean the nebulizer. The controller is the reusable part: the Pro-X Controller is wiped with an alcohol-based or quaternary wipe. The manual states that only trained medical personnel should operate the device.
The 510(k) summary states the service life limits that matter for stock rotation: intermittent use for a maximum of 28 days at 4 treatments per day, and continuous use validated for a maximum of 7 days with the nebulizer and the Continuous Nebulization Tube Set. The manual gives an upper limit of 12 mL per hour in continuous mode and notes that continuous mode runs only on AC power.
By contrast, the PARI bundle contains a reusable nebulizer and a backup nebulizer with a compressor that carries a five-year warranty, and carries separate billing codes for compressor and nebulizer. The cleaning, replacement interval and disinfection of the LC Sprint are specified in PARI’s own instructions, which this page does not reproduce.
Where it matters for labs, clinics and supply decisions
Four points follow from the sources, with no purchasing recommendation implied.
- Classification and prescription status. The Solo is a Class 2 prescription device (product code CAF, 21 CFR 868.5630; prescription use under 21 CFR 801 Subpart D).
- Setting. The 2024 clearance describes hospital use, with homecare on ventilation only for the USB Controller System. The Rev L manual says hospital use only. Setting statements belong to a specific labelling revision, so records should note which one was consulted.
- Component identity. A requisition that says only “Vios” or only “Solo” can name a compressor, a controller or a nebulizer. Aerogen splits the nebulizer from the controller; PARI splits the compressor (Vios) from the nebulizer (LC Sprint). Item descriptions should name each part.
- Billing codes for the PARI bundle. PARI’s page lists HCPCS E0570 for the compressor and A7005 for the reusable nebulizer. Coverage rules for those codes are set by payers and are not discussed here.
For research laboratories, the practical lesson is about reporting. Aerosol output figures depend on the drug, the nebulizer and the test method, as the manual itself says, so a methods section that names a nebulizer should cite the method and device configuration used rather than a catalogue figure. For how output differs between delivery technologies in general, see our comparison metered-dose inhalers versus dry powder inhalers.
Common misunderstandings
“PARI Vios is a nebulizer”
It is the compressor. PARI’s product page lists the nebulizer separately as the LC Sprint, with its own HCPCS code (A7005) distinct from the compressor code (E0570).
“Mesh and jet nebulizers can be compared on one number”
Only when the figure comes from the same test. The Aerogen manual reports output under EN 13544-1 and cascade impactor conditions and cautions that performance varies with drug and nebulizer; PARI’s product page does not state comparable figures.
“The Solo is a home nebulizer”
The Solo Nebulizer System is cleared for the hospital environment. The homecare statement in K232507 applies to the USB Controller System and to patients on ventilation only.
“A single-patient-use nebulizer can be cleaned and reused”
The instruction manual says not to attempt to clean the nebulizer and that it is not for use on more than one patient. The intermittent (28 day) and continuous (7 day) limits come from the 510(k) summary.
“The 2024 clearance and the Rev L manual disagree”
They describe different controller generations (USB Controller versus Pro-X Controller), as the table above shows. Check the document revision that ships with the product you hold.
FAQ
What is the PARI Vios?
A compressor. PARI’s page for Vios with LC Sprint gives a maximum pressure of 34 PSI (2.3 bar) and maximum flow of 8.5 L/min, and nominal 18 PSI (1.2 bar) and 4.5 L/min when used with a PARI LC reusable nebulizer.
What is the PARI LC Sprint?
The reusable jet nebulizer in the Vios with LC Sprint bundle (part 310F35-LCS). For the related LC Plus, see PARI LC Plus explained.
Does the Aerogen Solo need compressed gas?
No. The 510(k) summary states it operates without a compressed gas source, using a vibrating mesh element driven electrically.
Is Aerogen Solo single-use?
It is single-patient use. Per the 510(k) summary it can be used intermittently for a maximum of 28 days (4 treatments a day) and continuously for a validated maximum of 7 days with the Continuous Nebulization Tube Set.
What age is Aerogen Solo cleared for?
Pediatric patients 29 days or older and adult patients, per K232507.
Is it a prescription device?
Yes. The 510(k) summary identifies it as prescription use under 21 CFR 801 Subpart D.
Sources
- FDA 510(k) K232507 decision letter and summary, Aerogen Solo Nebulizer System and Aerogen USB Controller System, decision 2024-05-10: accessdata.fda.gov (read 2026-11-12).
- openFDA device classification, product code CAF, 21 CFR 868.5630, and 510(k) records K232507 and K251615: api.fda.gov (read 2026-11-12).
- Aerogen Solo System Instruction Manual 30-674 Rev L (US), hosted by Hamilton Medical: hamilton-medical.com (read 2026-11-12).
- PARI Vios with LC Sprint product page: pari.com (read 2026-11-12).
Data: Aerogen Solo (vibrating mesh) versus PARI Vios with LC Sprint (compressor and jet nebulizer): attributes stated in FDA and manufacturer documents
Side-by-side of attributes that the FDA 510(k) summary K232507, the Aerogen Solo instruction manual Rev L and PARI's Vios with LC Sprint product page each state. Cells marked Not stated in source were not published in the document read; no values were estimated.
Period covered: 2024/2026. Coverage: United States.
| Attribute | Aerogen Solo | PARI Vios with LC Sprint |
|---|---|---|
| Technology | Vibrating mesh, approx. 128 kHz, electrically driven | Compressor-driven reusable nebulizer (LC Sprint) |
| Compressed gas source needed | No | Compressor supplied (Vios) |
| Device role named by source | Nebulizer (FDA product code CAF, Class 2, 21 CFR 868.5630) | Vios is the compressor; LC Sprint is the nebulizer |
| Reuse | Nebulizer single-patient use, not to be cleaned; controller reusable | Reusable nebulizer plus backup nebulizer in bundle |
| Maximum reservoir capacity | 6 mL | Not stated in source |
| Maximum pressure / flow stated | Operates up to 90 cm H2O circuit pressure | Compressor max 34 PSI (2.3 bar), 8.5 L/min; nominal 18 PSI (1.2 bar), 4.5 L/min with PARI LC reusable nebulizer |
| Weight | Nebulizer 13.5 g | Compressor 3 lbs |
| Age groups stated | Pediatric 29 days or older, and adult | Adult and pediatric |
| Setting stated | Hospital; homecare on ventilation only for USB Controller System | Not stated in source |
| HCPCS codes listed | Not stated in source | E0570 (compressor), A7005 (reusable nebulizer) |
| Warranty stated | Not stated in source | 5 years (compressor) |
Sources
- FDA 510(k) K232507 decision letter and summary (accessed 2026-11-12)
- Aerogen Solo System Instruction Manual 30-674 Rev L (US) (accessed 2026-11-12)
- PARI Vios with LC Sprint product page (accessed 2026-11-12)
Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.







